Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 4/20 | 0.61 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.61 |
| ▸ | OGT | O15294 | 1/20 | 0.53 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KMO | O15229 | 1/20 | 0.50 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 3/20 | 0.47 |
| ▸ | NOS2 | P35228 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.45 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221802 | 0.84 | NOS1 (0.61) | NOS1PSMB8OGTPDE3BPDE3A | |
| SCHEMBL29748363 | 0.84 | NOS1 (0.61) | NOS1PSMB8OGTPDE3BPDE3A | |
| SCHEMBL8777948 | 0.77 | KDM4E (0.50) | NOS1PSMB8OGTKDM4EALDH1A1 | |
| SCHEMBL1147630 | 0.77 | F2 (0.56) | KMT2ASMN1; SMN2NPC1MAPTRAB9A | |
| SCHEMBL6023537 | 0.77 | NOS1 (0.53) | NOS1OGTPDE3BPDE3AKDM4E | |
| SCHEMBL8131111 | 0.76 | NOS1 (0.61) | NOS1OGTPDE3BPDE3AKDM4E | |
| SCHEMBL1519891 | 0.76 | NOS1 (0.72) | NOS1PSMB8OGTPDE3BPDE3A | |
| SCHEMBL11597370 | 0.76 | NOS1 (0.61) | NOS1OGTPDE3BPDE3AKDM4E | |
| SCHEMBL993598 | 0.76 | NOS1 (0.61) | NOS1OGTPDE3BPDE3AKDM4E | |
| SCHEMBL118671 | 0.76 | PSMB8 (1.00) | NOS1PSMB8KDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053786-A1 | FORMULATIONS OF RADIPRODIL | GRIN THERAPEUTICS INC (US) | 2026-02-26 | — | — | US | claimed |
| US-20250288518-A1 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | GRIN THERAPEUTICS, INC. | 2025-09-18 | — | — | US | claimed |
| WO-2025137652-A2 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | GRIN THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250127770-A1 | FORMULATIONS OF RADIPRODIL | GRIN THERAPEUTICS, INC. | 2025-04-24 | — | — | US | claimed |
| EP-4380547-A1 | FORMULATIONS OF RADIPRODIL | Grin Therapeutics, Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| CN-118019521-A | Preparation of raldil | 格林治疗股份有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2023014956-A9 | FORMULATIONS OF RADIPRODIL | GRIN THERAPEUTICS, INC. (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023014956-A1 | FORMULATIONS OF RADIPRODIL | GRIN THERAPEUTICS, INC. (US) | 2023-02-09 | — | — | WO | claimed |
| CN-105018506-A | Hydrolase of benzoxazolone compound, gene for coding hydrolase and engineering strain containing gene and application thereof | UNIV NANJING AGRICULTURAL | 2015-11-04 | — | — | CN | claimed |
| EP-2414346-B1 | AUTOTAXIN INHIBITORS | MERCK PATENT GMBH (DE) | 2015-06-24 | — | — | EP | claimed |
| WO-2010025871-A1 | 4-HALOGEN ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES FOR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | claimed |
| WO-2010025863-A2 | 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | claimed |
| EP-2161259-A1 | 4-Haloalkyl substituted Diaminopyrimidine | Bayer CropScience AG (DE) | 2010-03-10 | — | — | EP | claimed |
| CN-101621927-A | Diaminopyrimidines as fungicides | BAYER CROPSCIENCE AG | 2010-01-06 | — | — | CN | claimed |
| EP-2129222-A1 | DIAMINOPYRIMIDINES AS FUNGICIDES | Bayer CropScience AG (DE) | 2009-12-09 | — | — | EP | claimed |
| WO-2009115267-A2 | DIAMINOPYRIMIDINES AS PLANT PROTECTION AGENTS | BAYER CROPSCIENCE AG (DE) | 2009-09-24 | — | — | WO | claimed |
| WO-2008107096-A1 | DIAMINOPYRIMIDINES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2008-09-12 | — | — | WO | claimed |
| US-4997920-A | Dyeing polyolefins | CIBA-GEIGY CORPORATION (US) | 1991-03-05 | — | — | US | claimed |
| US-4670486-A | Polymer composition pigmented with copper or nickel complexes of ligands containing a semicarbazone moiety | CIBA-GEIGY CORPORATION (US) | 1987-06-02 | — | — | US | claimed |
| EP-0086126-B1 | IMIDAZOLINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL APPLICATION | SYNTHELABO (FR) | 1985-07-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053786-A1 | FORMULATIONS OF RADIPRODIL | GRIN2D, GRIN2A, GRIN2B | NOS1 2825/4885PSMB8 3443/4885OGT 4419/4885 |
| US-20250288518-A1 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | CLN6, GABARAPL2, GABARAPL1 | NOS1 4459/4885PSMB8 2522/4885OGT 3416/4885 |
| US-20250127770-A1 | FORMULATIONS OF RADIPRODIL | GABARAPL2, PARL, GABARAPL1 | NOS1 4222/4885PSMB8 2730/4885OGT 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.